Standard LS Parameter Estimators Ensure Finite Convergence Time for Linear Regression Equations Under an Interval Excitation Assumption
Memorias del Congreso Nacional de Control Automático · 17.10.2025 · 8 (1) · 92-96
DOI: 10.58571/cnca.amca.2025.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Memorias del Congreso Nacional de Control Automático, online erschienen am 17.10.2025. Verfasst von Romeo Ortega und 3 weiteren Autor:innen.
Abstract (Originalsprache)
In this brief note we recall the little-known fact that, for linear regression equations with intervally excited (IE) regressors, standard Least Squares parameter estimators ensure finite convergence time of the estimated parameters. The convergence time being equal to the time length needed to comply with the IE assumption. As is wellknown, IE is necessary and sufficient for the identifiability of the linear regression equation—hence, it is the weakest assumption for the on- or off-line solution of the parameter estimation problem.
Zitieren
APA
Ortega, R., Romero, J. G., Aranovskiy, S., & Tao, G. (2025). Standard LS Parameter Estimators Ensure Finite Convergence Time for Linear Regression Equations Under an Interval Excitation Assumption. Memorias del Congreso Nacional de Control Automático, 8(1), 92-96. https://doi.org/10.58571/cnca.amca.2025.016
Vancouver
Ortega R, Romero JG, Aranovskiy S, Tao G. Standard LS Parameter Estimators Ensure Finite Convergence Time for Linear Regression Equations Under an Interval Excitation Assumption. Memorias del Congreso Nacional de Control Automático. 2025;8(1):92-96. doi:10.58571/cnca.amca.2025.016
BibTeX
@article{Ortega2025,
author = {Ortega, Romeo and Romero, José Guadalupe and Aranovskiy, Stanislav and Tao, Gang},
title = {Standard LS Parameter Estimators Ensure Finite Convergence Time for Linear Regression Equations Under an Interval Excitation Assumption},
journal = {Memorias del Congreso Nacional de Control Automático},
year = {2025},
volume = {8},
number = {1},
pages = {92--96},
doi = {10.58571/cnca.amca.2025.016}
}
EUVIMED